Company profile

Beijing InnoCare Pharma Tech Co.

9969 · HKEX (dual-listed STAR Market 688428.SS) -- parent InnoCare Pharma Limited

Public Market Listing

9969HKEX (dual-listed STAR Market 688428.SS) -- parent InnoCare Pharma Limited

HKEX (dual-listed STAR Market 688428.SS) -- parent InnoCare Pharma Limited primary exchange listing

Live quotes, historical charts, and market capitalization for Beijing InnoCare Pharma Tech Co. are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(4 total)
4Total Assets
0Approved
2Phase 3 / Filed
2Phase 1–2 / Early
4Diseases
Quick filter:
Showing 4 of 4 assets
Target & Modality
ICP-332
Phase 3
TYK2/JAK1Small molecule
Atopic DermatitisPsoriasis
ICP-488
Phase 3
TYK2Small molecule
Psoriasis
ICP-490
Phase 2
Cereblon E3 ubiquitin-ligaseSmall molecule
Multiple Myeloma
ICP-248
Phase 1
BCL-2
Acute Myeloid Leukemia

Upcoming events

Research

Unlock the company readout calendar

Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.

Financial reports

Research

Unlock sourced financial history

Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.

Educational data tool. Figures are sourced from company filings and press releases: see each row's filing link. Share price is delayed (~15min) and refreshed periodically, not a real-time feed.